Successful antibody behind the billion crown Life Science deal
Published 25 August 2015 An antibody that did not fulfil its purpose against the disease multiple sclerosis, MS, instead made its big break in cancer research and is now starring in southern Sweden’s largest licensing agreement in Life Science history. The “father” of the antibody is Professor Carl Borrebaeck. Carl Borrebaeck. Photo: Gunnar Menander It is one of the windiest days in late summer, a
https://www.staff.lu.se/article/successful-antibody-behind-billion-crown-life-science-deal - 2025-05-01